NASDAQ: CNTXContext Therapeutics Inc Stock Ownership - Who owns Context Therapeutics?
Insider buying vs selling
Have Context Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CNTX insiders and whales buy or sell their stock.
CNTX Shareholders
What type of owners hold Context Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Martin A. Lehr | 1.18% | 1,079,891 | $195.46k | Insider |
| Alex C. Levit | 0.09% | 81,983 | $14.84k | Insider |
| Jennifer Lynn Minaiazary | 0.09% | 80,010 | $14.48k | Insider |
| Evan G. Dick | 0.06% | 56,373 | $10.20k | Insider |
| Tarek Sahmoud | 0.01% | 10,000 | $1.81k | Insider |
| Blackrock Inc | 0.01% | 6,139 | $1.11k | Institution |
| Philip W. Kantoff | 0.00% | 3,533 | $639.47 | Insider |
| Vanguard Capital Management LLC | 0.00% | 3,432 | $621.19 | Institution |
| Acadian Asset Management LLC | 0.00% | 1,990 | $360.19 | Institution |
| Geode Capital Management LLC | 0.00% | 1,895 | $343.00 | Institution |
CNTX vs Biotech Stocks
Context Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.